GPAT3 and infection: The reactivity of P35-MAG1, MIC1-ROP1, and MAG1-ROP1 protein preparations with anti-T. gondii IgG antibodies in serum samples from patients with the acute phase of infection was 100%, 77.3%, and 86.4%, respectively.